Skip to main content

Dose Radiopharmaceutical Science Makes Sense/Over on MR Contrast Media Agents or Not?

Buy Article:

$68.00 + tax (Refund Policy)

Full text Available.





Keywords: MR Contrast Media; MRI instrument; Magnetic Resonance Contrast Media Imaging Agent; Nuclear Magnetic Resonance; Nuclear Pharmaceutical sciences; Oragno-Inorgano-Metalic-Chemistry; PET; Positron Emission Tomography; Radiophar-maceutical sciencesparatus; SPECT; Single Photon Emission Computed Tomography; radio-labeled ligand

Document Type: Research Article

Publication date: 01 October 2010

More about this publication?
  • Current Radiopharmaceuticals publishes original research articles, letters, reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations. The scope of the journal covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content